tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

IVVD Stock Latest News

Invivyd announces continued neutralizing activity of PEMGARDA
The FlyInvivyd announces continued neutralizing activity of PEMGARDA
8d ago
IVVD
Invivyd price target lowered to $3.55 from $9.50 at Morgan Stanley
PremiumThe Fly
Invivyd price target lowered to $3.55 from $9.50 at Morgan Stanley
2M ago
IVVD
Invivyd price target lowered to $10 from $15 at H.C. Wainwright
PremiumThe Fly
Invivyd price target lowered to $10 from $15 at H.C. Wainwright
2M ago
IVVD
Invivyd’s Q3 2024: Revenue Growth and Strategic Developments
PremiumCompany Announcements
Invivyd’s Q3 2024: Revenue Growth and Strategic Developments
2M ago
IVVD
Invivyd reports Q3 EPS (51c) vs (36c) last year
PremiumThe Fly
Invivyd reports Q3 EPS (51c) vs (36c) last year
2M ago
IVVD
Invivyd announces NEJM published letter to editor on PEMGARDA
PremiumThe FlyInvivyd announces NEJM published letter to editor on PEMGARDA
2M ago
IVVD
Invivyd announces manuscript preprint conveying data from CANOPY Phase 3 trial
Premium
The Fly
Invivyd announces manuscript preprint conveying data from CANOPY Phase 3 trial
2M ago
IVVD
IVVD Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
IVVD Upcoming Earnings Report: What to Expect?
2M ago
IVVD
U.S. drugmakers shifting away from Chinese supply-chain partners, WSJ says
PremiumThe Fly
U.S. drugmakers shifting away from Chinese supply-chain partners, WSJ says
3M ago
AZN
VIR
Alphabet upgraded, Boeing downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Alphabet upgraded, Boeing downgraded: Wall Street’s top analyst calls
3M ago
BA
CWH
Invivyd initiated with a Buy at EF Hutton
PremiumThe Fly
Invivyd initiated with a Buy at EF Hutton
3M ago
IVVD
Invivyd pulls 2024 revenue guidance on ‘recent growth headwind’
PremiumThe Fly
Invivyd pulls 2024 revenue guidance on ‘recent growth headwind’
3M ago
IVVD
Invivyd reports preliminary Q3 PEMGARDA product revenue $9.3M
PremiumThe FlyInvivyd reports preliminary Q3 PEMGARDA product revenue $9.3M
3M ago
IVVD
Invivyd announces 12-month exploratory data from CANOPY Phase 3 trial
Premium
The Fly
Invivyd announces 12-month exploratory data from CANOPY Phase 3 trial
3M ago
IVVD
Invivyd announces FDA update on Pemgarda fact sheet for SARS-CoV-2 variants
Premium
The Fly
Invivyd announces FDA update on Pemgarda fact sheet for SARS-CoV-2 variants
4M ago
IVVD
Invivyd provides virology data, analysis of SARS-CoV-2 structural biology
PremiumThe Fly
Invivyd provides virology data, analysis of SARS-CoV-2 structural biology
4M ago
IVVD
Invivyd announces business readiness update, granted EUA for PEMGARDA
PremiumThe Fly
Invivyd announces business readiness update, granted EUA for PEMGARDA
4M ago
IVVD
Invivyd doses first participants in Phase 1 trial of VYD2311
PremiumThe Fly
Invivyd doses first participants in Phase 1 trial of VYD2311
5M ago
IVVD
Invivyd’s Pemgarda shows neutralizing activity against SARS-CoV-2 variants
PremiumThe Fly
Invivyd’s Pemgarda shows neutralizing activity against SARS-CoV-2 variants
5M ago
IVVD
Invivyd gives efficacy data from ongoing CANOPY trial of PEMGARDA for Covid-19
PremiumThe FlyInvivyd gives efficacy data from ongoing CANOPY trial of PEMGARDA for Covid-19
5M ago
IVVD
Mars buys Kellanova, Cardinal Health reports Q4 beat: Morning Buzz
Premium
The Fly
Mars buys Kellanova, Cardinal Health reports Q4 beat: Morning Buzz
5M ago
K
GM
Invivyd reports Q2 EPS (40c), consensus (37c)
Premium
The Fly
Invivyd reports Q2 EPS (40c), consensus (37c)
5M ago
IVVD

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >